Topics

New FDA Commissioner Promises More Of Same, But Better

08:41 EDT 1 May 2019 | SCRIP

No major FDA policy shifts on generics or biosimilars should be expected under new commissioner Ned Sharpless. Rather, the focus...

      

Related Stories

 

Original Article: New FDA Commissioner Promises More Of Same, But Better

NEXT ARTICLE

More From BioPortfolio on "New FDA Commissioner Promises More Of Same, But Better"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...